Yuyang Feng

Oct 19, 2024 | mdpi.com | Yuyang Feng |Yifei Zhang |Lin Wang |Shiqiang Wang

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Sep 11, 2023 | onlinelibrary.wiley.com | Lu Tian |Surui Yao |Chu Hao |Yuyang Feng

1 INTRODUCTION Gastric cancer (GC) is one of the most malignant carcinomas and the fourth leading cause of cancer-related death worldwide, and it is estimated that approximately over 1 million new GC cases emerged in 2020.1 GC is a highly heterogenetic disease with a poor prognosis, and its molecular mechanism is not well understood.2 Consequently, continuous efforts are needed to clarify its molecular mechanisms and determine new therapeutic targets for GC.